IL112088A - Stable stem cell factor formulations with improved stability and methods for their production - Google Patents

Stable stem cell factor formulations with improved stability and methods for their production

Info

Publication number
IL112088A
IL112088A IL11208894A IL11208894A IL112088A IL 112088 A IL112088 A IL 112088A IL 11208894 A IL11208894 A IL 11208894A IL 11208894 A IL11208894 A IL 11208894A IL 112088 A IL112088 A IL 112088A
Authority
IL
Israel
Prior art keywords
scf
formulations
formulation
lyophilized
sucrose
Prior art date
Application number
IL11208894A
Other languages
English (en)
Other versions
IL112088A0 (en
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of IL112088A0 publication Critical patent/IL112088A0/xx
Publication of IL112088A publication Critical patent/IL112088A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11208894A 1993-12-22 1994-12-20 Stable stem cell factor formulations with improved stability and methods for their production IL112088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/172,507 US6288030B1 (en) 1993-12-22 1993-12-22 Stem cell factor formulations and methods

Publications (2)

Publication Number Publication Date
IL112088A0 IL112088A0 (en) 1995-03-15
IL112088A true IL112088A (en) 2001-04-30

Family

ID=22627993

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11208894A IL112088A (en) 1993-12-22 1994-12-20 Stable stem cell factor formulations with improved stability and methods for their production

Country Status (14)

Country Link
US (4) US6288030B1 (zh)
EP (1) EP0732935B1 (zh)
CN (1) CN1105575C (zh)
AT (1) ATE173402T1 (zh)
AU (1) AU696860B2 (zh)
CA (1) CA2182970C (zh)
DE (1) DE69414723T2 (zh)
DK (1) DK0732935T3 (zh)
ES (1) ES2123951T3 (zh)
HK (1) HK1008815A1 (zh)
IL (1) IL112088A (zh)
NZ (1) NZ278252A (zh)
WO (1) WO1995017206A1 (zh)
ZA (1) ZA9410189B (zh)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
GB9515839D0 (en) * 1995-08-02 1995-10-04 Q One Biotech Ltd Feline stem cell factor
TW518219B (en) * 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
US6017876A (en) 1997-08-15 2000-01-25 Amgen Inc. Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
US6541033B1 (en) 1998-06-30 2003-04-01 Amgen Inc. Thermosensitive biodegradable hydrogels for sustained delivery of leptin
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
US6500418B1 (en) * 1999-02-12 2002-12-31 The Washington University Stimulating neutrophil function to treat inflammatory bowel disease
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US6472208B1 (en) * 1999-12-13 2002-10-29 Héma-Québec Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
CA2678490A1 (en) 2000-12-06 2002-06-13 Robert J. Hariri Isolated placental perfusate and placental cells isolated therefrom
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
JP2004528021A (ja) * 2001-02-14 2004-09-16 アンスロジェネシス コーポレーション 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
JP3963786B2 (ja) * 2002-06-11 2007-08-22 富士通株式会社 情報処理装置
BR0316695A (pt) * 2002-11-26 2005-10-18 Anthrogenesis Corp Unidade citoterapêutica, kit para tratamento, método de tratamento de uma enfermidade, biblioteca de unidades citoterapêuticas e método de tratamento de um paciente
BRPI0407427A (pt) * 2003-02-13 2006-01-24 Anthrogenesis Corp Método para tratar um paciente e para tratar a mielodisplasia
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
EP1694328A4 (en) * 2003-12-02 2010-02-17 Celgene Corp METHOD AND COMPOSITIONS FOR THE TREATMENT AND SUPPLY OF HEMOGLOBINOPATHY AND ANEMIA
WO2005067889A1 (en) 2003-12-30 2005-07-28 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
US20080311078A1 (en) 2005-06-14 2008-12-18 Gokarn Yatin R Self-Buffering Protein Formulations
US20070190047A1 (en) * 2005-07-29 2007-08-16 Amgen, Inc. Formulations that inhibit protein aggregation
PE20070771A1 (es) 2005-10-13 2007-08-11 Anthrogenesis Corp Inmunomodulacion mediante el uso de celulas madres de la placenta
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
ES2708933T3 (es) 2005-12-29 2019-04-12 Celularity Inc Poblaciones de células madre placentarias
AR059066A1 (es) 2006-01-27 2008-03-12 Amgen Inc Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
EP1854478A1 (en) * 2006-05-12 2007-11-14 Cytos Biotechnology AG Nicotine-carrier vaccine formulation
PT2084268T (pt) * 2006-10-23 2019-01-28 Celularity Inc Métodos e composições para o tratamento de defeitos ósseos com populações de células placentárias
RS52921B (en) * 2007-02-12 2014-02-28 Anthrogenesis Corporation TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS
US20100172830A1 (en) * 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
KR20190050867A (ko) * 2007-09-26 2019-05-13 안트로제네시스 코포레이션 인간 태반 관류액으로부터의 혈관형성 세포
ES2530995T3 (es) 2007-09-28 2015-03-09 Anthrogenesis Corp Supresión de tumor usando perfusato placentario humano y células asesinas naturales intermediarias que provienen de placenta humana
NO2217329T3 (zh) * 2007-11-07 2018-06-09
EP2329012B1 (en) * 2008-08-20 2020-05-20 Celularity, Inc. Treatment of stroke using isolated placental cells
NZ591292A (en) * 2008-08-20 2012-10-26 Anthrogenesis Corp Improved cell composition and methods of making the same
CA2734446C (en) * 2008-08-22 2017-06-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
JP5869342B2 (ja) 2008-11-19 2016-02-24 アンスロジェネシス コーポレーション 羊膜由来接着細胞
NZ602569A (en) * 2008-11-21 2014-03-28 Anthrogenesis Corp Treatment of diseases, disorders or conditions of the lung using placental cells
NZ597436A (en) * 2009-07-02 2014-08-29 Anthrogenesis Corp Method of producing erythrocytes without feeder cells
EP3284818B1 (en) * 2010-01-26 2022-03-09 Celularity Inc. Treatment of bone-related cancers using placental stem cells
TW202011974A (zh) 2010-04-07 2020-04-01 美商安瑟吉納西斯公司 利用胎盤幹細胞之血管新生
TW201138792A (en) 2010-04-08 2011-11-16 Anthrogenesis Corp Treatment of sarcoidosis using placental stem cells
WO2012009422A1 (en) 2010-07-13 2012-01-19 Anthrogenesis Corporation Methods of generating natural killer cells
MX349054B (es) 2010-09-28 2017-07-07 Aegerion Pharmaceuticals Inc Leptinas altamente solubles.
AR093183A1 (es) 2010-12-31 2015-05-27 Anthrogenesis Corp Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
TWI602570B (zh) 2011-06-01 2017-10-21 安瑟吉納西斯公司 使用胎盤幹細胞之疼痛治療
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
WO2014123879A1 (en) 2013-02-05 2014-08-14 Anthrogenesis Corporation Natural killer cells from placenta
EP4209499A1 (en) 2015-08-13 2023-07-12 Amgen Inc. Charged depth filtration of antigen-binding proteins

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165370A (en) 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
JPS5534001A (en) * 1978-08-28 1980-03-10 Noda Sangyo Kagaku Kenkyusho Stabilization of sarcosine oxidase
US4783441A (en) 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
JPS5874617A (ja) 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
JPS58134991A (ja) * 1981-12-28 1983-08-11 Takeda Chem Ind Ltd セラチオペプチタ−ゼの安定化法
JPS59134730A (ja) 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
FI86885C (fi) 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
SE8501050D0 (sv) 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
CA1292686C (en) 1986-10-27 1991-12-03 Ze'ev Shaked Pharmaceutical compositions of recombinant interleukin-2 and formulation process
NZ226170A (en) 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
US5096885A (en) 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
EP0381345B1 (en) 1989-01-30 1994-07-13 Corint, Ltd. Aqueous liquid desmopressin-CMC pharmaceutical composition
JPH02268681A (ja) * 1989-04-07 1990-11-02 Green Cross Corp:The ウロキナーゼ前駆体の安定化方法及び乾燥製剤
CA2028848A1 (en) * 1989-04-11 1990-10-12 Tapan Audhya Lyophilized peptide formulations
WO1991005795A1 (en) 1989-10-16 1991-05-02 Amgen Inc. Stem cell factor
DE69034258D1 (de) 1989-10-16 2008-09-18 Amgen Inc Stamzellfaktor
SE465222C5 (sv) 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
DE4001451A1 (de) 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
WO1992000376A1 (en) 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
EP0618807B1 (en) * 1991-12-20 2002-11-13 Novo Nordisk A/S A stabilized pharmaceutical formulation comprising growth hormone and histidine
US5192743A (en) 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
SK282483B6 (sk) * 1992-10-02 2002-02-05 Genetics Institute, Inc. Stabilná kompozícia koagulačného faktora VIII, spôsob jej prípravy a stabilizácie

Also Published As

Publication number Publication date
EP0732935B1 (en) 1998-11-18
US20020013258A1 (en) 2002-01-31
CA2182970A1 (en) 1995-06-29
NZ278252A (en) 1998-04-27
ES2123951T3 (es) 1999-01-16
WO1995017206A1 (en) 1995-06-29
AU696860B2 (en) 1998-09-17
DK0732935T3 (da) 1999-08-02
AU1442295A (en) 1995-07-10
CN1142771A (zh) 1997-02-12
US5965522A (en) 1999-10-12
DE69414723D1 (de) 1998-12-24
EP0732935A1 (en) 1996-09-25
HK1008815A1 (en) 1999-05-21
CN1105575C (zh) 2003-04-16
US6020469A (en) 2000-02-01
IL112088A0 (en) 1995-03-15
ATE173402T1 (de) 1998-12-15
ZA9410189B (en) 1995-08-25
US6288030B1 (en) 2001-09-11
CA2182970C (en) 2000-11-28
DE69414723T2 (de) 1999-07-22

Similar Documents

Publication Publication Date Title
AU696860B2 (en) Lyophilized stem cell factor formulations
CA2079780C (en) Methods and formulations for stabilizing fibroblast growth factor
EP0820299B1 (en) Formulations for il-12
EP1827483B1 (en) Therapeutic formulations of keratinocyte growth factor
BRPI0002276B1 (pt) Conjugado, composição que compreende conjugados, composição farmacêutica, utilização de um conjugado ou composição e processso para a preparação de compostos
US6077829A (en) Stable pharmaceutical composition of BDNF
EP0787497A2 (en) Pharmaceutical preparation containing human growth hormone
CN113274486A (zh) 一种稳定的酸性成纤维细胞生长因子制剂及其制备方法和应用
US5885962A (en) Stem cell factor analog compositions and method
JPH03505334A (ja) 凍結乾燥されたペプチド製剤
US4933433A (en) Recombinant interleukin-2 composition and process for making it
MXPA00005214A (es) Una jeringa de una dosis, que comprende una composicion de proteina liofilizada, para administrar un volumen menor de 0.5 ml.
KR20080041661A (ko) 생체적합성 폴리머와 컨쥬게이트된 인간 성장 호르몬
AU598300B2 (en) Succinylated interleukin-2 for pharmaceutical compositions
EP0557319B1 (en) Therapeutic use of fibroblast growth factor
JPH05331199A (ja) 凍結乾燥した酸性線維芽細胞成長因子
EP0494664A1 (en) Human bFGF derivatives, their analogs and process for their production
JPH0378847B2 (zh)
CN1485341A (zh) 一种应用重组技术对生长因子进行改造的方法
JPH0418031A (ja) 損傷治癒促進剤
EP0475719A2 (en) Platelet derived growth regulating peptide
JPH08259459A (ja) 巨核球増殖分化剤
MXPA97005959A (en) Formulations for the il

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees